Client login

API, Chemical Development & Analytical Services / Limit tests by XRPD

Poster

Limit tests by XRPD

Almac presented a poster at the 16th European Powder Diffraction Conference detailing the detection of low percentage of polymorphic impurities in fixed-dose combination tablets by XRPD.
Access the poster to find out more:

View Resource

Almac API, Chemical Development, Analytical & Solid State Services

Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).

We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.

Learn More

We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.

Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.

Learn More

You may also be interested in

Article

Bioalkylation Strategies to Synthesize Allylated Tetrahydroisoquinolines by Using Norcoclaurine Synthase and O-Methyltransferases

Almac Voice

The development of cutaneous limits for elemental impurities

Stay up-to-date with the latest from Almac

Join our mailing list

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies

Download here instantly

Bioalkylation Strategies to Synthesize Allylated Tetrahydroisoquinolines by Using Norcoclaurine Synthase and O-Methyltransferases

The development of cutaneous limits for elemental impurities